Clinical trial
Observational Study With Metronomic Oral Vinorelbine in Elderly Patients With Locally Advanced / Metastatic Non-small-cell Lung Cancer (NSCLC)
NCT04208854 is registered in ClinicalTrials.gov with International Group of Endovascular Oncology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Study With Metronomic Oral Vinorelbine in Elderly Patients With Locally Advanced / Metastatic Non-small-cell Lung Cancer (NSCLC)
- Lead sponsor
- International Group of Endovascular Oncology
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 18, 2018
- Completion date
- May 18, 2020
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
locally advanced/ metastatic nsclc